EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytoskeletal Protein 4.1R Inhibits BCR-Mediated B-Cell Activation by Restraining AKT1 Phosphorylation

Yuying Guo iD, Dandan Fan iD, Denghui Liu, Qi Shao, Siyao Sang, Yuting Niu, Lixiang Chen iD, Taotao Liang iD

Cells · 13.07.2026 · 15 (14) · 1256

DOI: 10.3390/cells15141256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 13.07.2026. Verfasst von Yuying Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, B-Lymphocytes, Receptors, Antigen, B-Cell, Lymphocyte Activation. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Province Medical Science and Technology Talents Overseas Training Program, Henan Province Traditional Chinese Medicine Science and Technology Research Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B-cell receptor (BCR) is indispensable for B-cell responses, and its signaling relies on the rearrangement of cytoskeletal proteins. Cytoskeletal protein 4.1R has been previously implicated in the regulation of immune function. However, the specific role of 4.1R in BCR-mediated B-cell activation remains unknown. Here, we performed single-cell RNA (scRNA) sequencing on splenic B cells isolated from wild-type (WT) and 4.1R-knockout (4.1R-KO) mice to systematically characterize the functional contribution of 4.1R to B-cell biology. Transcriptomic analyses suggested a critical role for 4.1R in modulating BCR signaling. Ex vivo stimulation of primary B cells with anti-IgM demonstrated that 4.1R-KO B cells exhibited marked overactivation, hyperproliferation, and enhanced antibody secretion. Furthermore, unbiased phosphoproteomic profiling, identified sustained AKT1 phosphorylation as a key feature in 4.1R-KO B cells. Subsequent functional validation confirmed that 4.1R regulates BCR signaling by constraining AKT1 activation. Mechanistically, 4.1R rapidly colocalized with the coreceptor CD19 at the plasma membrane upon BCR engagement, and co-immunoprecipitation confirmed their physical interaction. Loss of 4.1R disrupted this interaction and resulted in sustained and amplified AKT1 phosphorylation (but not AKT2) in stimulated B cells. Collectively, our findings identify 4.1R as a novel negative regulator of BCR signaling that interacts with CD19 to constrain AKT1 activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktB-LymphocytesReceptors, Antigen, B-CellLymphocyte ActivationMicrofilament ProteinsCytoskeletal ProteinsAnimalsPhosphorylationMiceMice, KnockoutSignal TransductionMice, Inbred C57BLMembrane ProteinsAntigens, CD19

Stichwörter der Autor:innen

AKT1 phosphorylationB-cell activationBCR signalingprotein 4.1R

Substanzen

Proto-Oncogene Proteins c-aktReceptors, Antigen, B-CellEpb41 protein, mouseAkt1 protein, mouseMicrofilament ProteinsMembrane ProteinsCytoskeletal ProteinsAntigens, CD19

Autor:innen und Institutionen

  • School of Life Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.
  • Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Department of Forensic Science and Technology, Zhengzhou Police University, Zhengzhou 450053, China.
  • School of Pharmaceutical Sciences, Zhengzhou University, 100 Science Road, Zhengzhou 450001, China.
  • State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Fudan University, Shanghai 200438, China.
  • School of Basic Medical Sciences, Zhongzhou Laboratory, Henan University, Kaifeng 475004, China.

ORCID-Profile: Yuying Guo, Dandan Fan, Lixiang Chen, Taotao Liang

Förderung

  • National Natural Science Foundation of China
  • Henan Province Medical Science and Technology Talents Overseas Training Program
  • Henan Province Traditional Chinese Medicine Science and Technology Research Special Project

Zitieren

APA

Guo, Y., Fan, D., Liu, D., Shao, Q., Sang, S., Niu, Y., Chen, L., & Liang, T. (2026). Cytoskeletal Protein 4.1R Inhibits BCR-Mediated B-Cell Activation by Restraining AKT1 Phosphorylation. Cells, 15(14), 1256. https://doi.org/10.3390/cells15141256

Vancouver

Guo Y, Fan D, Liu D, Shao Q, Sang S, Niu Y, et al. Cytoskeletal Protein 4.1R Inhibits BCR-Mediated B-Cell Activation by Restraining AKT1 Phosphorylation. Cells. 2026;15(14):1256. doi:10.3390/cells15141256

BibTeX
@article{Guo2026,
  author = {Guo, Yuying and Fan, Dandan and Liu, Denghui and Shao, Qi and Sang, Siyao and Niu, Yuting and Chen, Lixiang and Liang, Taotao},
  title = {Cytoskeletal Protein 4.1R Inhibits BCR-Mediated B-Cell Activation by Restraining AKT1 Phosphorylation},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {1256},
  doi = {10.3390/cells15141256}
}
Kostenlos starten →